Expression and prognostic significance of Cox-2 and p-53 in Hodgkin lymphomas: a retrospective study
- PMID: 20346139
- PMCID: PMC2853498
- DOI: 10.1186/1746-1596-5-19
Expression and prognostic significance of Cox-2 and p-53 in Hodgkin lymphomas: a retrospective study
Abstract
Background: Cyclooxygenase (cox) is the rate-limiting enzyme, which catalyzes the conversion of arachidonic acid into prostaglandins and contributes to the inflammatory process. Cyclooxygenase-2 (cox-2), which is one of the two isoforms, plays a role in tumor progression and carcinogenesis. p53 contributes to apoptosis, DNA renewal and cell cycle. Studies concerning the relationship of cox-2 and p53 expressions and carcinogenesis are available, but the association between cox-2 and p53 in Hodgkin lymphoma (HL) is not exactly known.In our study, we examined the association of cox-2 and p53 expression, with age, stage, histopathological subtype, and survival in HL. We also examined correlation between cox-2 and p53 expression.
Methods: Cox-2 and p53 expressions in Hodgkin-Reed Sternberg cells (HRS) were examined in 54 patients with HL depending on cox-2 expression, stained cases were classified as positive, and unstained cases as negative. Nuclear staining of HRS cells with p53 was evaluated as positive. The classifications of positivity were as follows: negative if<10%; (1+) if 10-25%; (2+) if 25-50%; (3+) if 50-75%, (4+) if >75%.
Results: Cox-2 and p53 expressions were found in 49 (80%) and 29 (46%) patients, respectively. There were differences between histological subtypes according to cox-2 expression (p = 0.012). Mixed cellular (MC) and nodular sclerosing (NS) subtypes were seen most of the patients and cox-2 expression was evaluated mostly in the mixed cellular subtype.There were no statistically significant relationships between p53 and the histopathological subtypes; or between p53, cox-2 and the factors including stage, age and survival; or between p53 and cox-2 expression (p > 0.05).
Conclusion: Considering the significant relationship between the cox-2 expression and the subtypes of HL, cox-2 expression is higher in MC and NS subtypes. However the difference between these two subtypes was not significant. This submission must be advocated by studies with large series.
Figures
Similar articles
-
Epstein-Barr virus infection correlates with the expression of COX-2, p16(INK4A) and p53 in classic Hodgkin lymphoma.Int J Clin Exp Pathol. 2013 Nov 15;6(12):2765-77. eCollection 2013. Int J Clin Exp Pathol. 2013. PMID: 24294363 Free PMC article.
-
Radiation therapy overcomes adverse prognostic role of cyclooxygenase-2 expression on Reed-Sternberg cells in early Hodgkin lymphoma.Int J Radiat Oncol Biol Phys. 2015 May 1;92(1):84-90. doi: 10.1016/j.ijrobp.2014.10.004. Epub 2014 Dec 2. Int J Radiat Oncol Biol Phys. 2015. PMID: 25475251
-
Expression of cyclooxygenase-2 in Hodgkin's lymphoma: its role in cell proliferation and angiogenesis.Leuk Lymphoma. 2006 Sep;47(9):1863-71. doi: 10.1080/10428190600685442. Leuk Lymphoma. 2006. PMID: 17064999
-
Apoptosis of Hodgkin-Reed-Sternberg cells in classical Hodgkin lymphoma revisited.APMIS. 2010 May;118(5):339-45. doi: 10.1111/j.1600-0463.2010.02600.x. APMIS. 2010. PMID: 20477808 Review.
-
The Hodgkin and Reed/Sternberg cell.Int J Biochem Cell Biol. 2005 Mar;37(3):511-7. doi: 10.1016/j.biocel.2003.10.025. Int J Biochem Cell Biol. 2005. PMID: 15618006 Review.
Cited by
-
Lower cyclooxygenase-2 expression is associated with recurrence of solitary non-muscle invasive bladder carcinoma.Diagn Pathol. 2012 Nov 5;7:152. doi: 10.1186/1746-1596-7-152. Diagn Pathol. 2012. PMID: 23126361 Free PMC article.
-
[Expression and prognostic value of COX- 2, p16(INK4A) and p53 in patients with classical Hodgkin lymphoma].Zhonghua Xue Ye Xue Za Zhi. 2015 Nov;36(11):926-32. doi: 10.3760/cma.j.issn.0253-2727.2015.11.008. Zhonghua Xue Ye Xue Za Zhi. 2015. PMID: 26632465 Free PMC article. Chinese.
-
Cyclooxygenase-2 expression as a predictor of outcome in colorectal carcinoma.World J Gastroenterol. 2012 Apr 21;18(15):1793-9. doi: 10.3748/wjg.v18.i15.1793. World J Gastroenterol. 2012. PMID: 22553404 Free PMC article.
-
Cyclooxygenase-2 expression in lymphoma in north-west of iran.Int J Hematol Oncol Stem Cell Res. 2013;7(1):1-4. Int J Hematol Oncol Stem Cell Res. 2013. PMID: 24505512 Free PMC article.
-
Immunohistochemistry with apoptotic-antiapoptotic proteins (p53, p21, bax, bcl-2), c-kit, telomerase, and metallothionein as a diagnostic aid in benign, borderline, and malignant serous and mucinous ovarian tumors.Diagn Pathol. 2012 Sep 20;7:124. doi: 10.1186/1746-1596-7-124. Diagn Pathol. 2012. PMID: 22995373 Free PMC article.
References
-
- Ioachim's HL. In: classical Hodgkin lymphoma. 4. Murphy J, McGough J, editor. Philadelphia: Lippincott Williams @ Wilkins; 2009. Medeiros Lymph Node Pathology; pp. 306–324.
-
- Stein H. In: WHO classification of tumours of haematopoietic and lymphoid tissues. Swerdlow SH, Campo E, Haris NL, Jaffe ES, Pileri SA, Stein H, ThieleJ, Vardiman JW, editor. Lyon: IARC Pres; 2008. Hodgkin lymphoma; pp. 321–334.
-
- Chang ET, Zheng T, Weir EG, Borowitz M, Mann RB, Spiegelman D, Mueller NE. Aspirin and the risk of Hodgkin's lymphoma in a population-based case-control study. J Natl Cancer Inst. 2004;96:305–315. - PubMed
-
- Rongen MM, Roers A, Küppers R, Rajewsky K, Hansman ML. Mutation of the p53 gene is not a typical feature of Hodgkin and Reed-Sternberg Cells in Hodgkin's disease. Neoplasia. 1999;94(5):1755–1760. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous